|
|
|
|
This randomized sham-controlled trial supports the abortive efficacy of a nVNS as early as 30 minutes and up to 60 minutes after an attack. Findings also suggest effective pain relief, tolerability, and practicality of nVNS for the acute treatment of episodic migraine. |
|